Drug intelligence / Profile preview

glucomannan + d-chiro-inositol + cinnamomum zeylanicum + inulin

Development stage
Unknown
Modality
Microbiome Therapeutics, Small Molecules
Administration
Oral
01

Overview

This is a multi-ingredient dietary supplement composed of glucomannan, D-chiro-inositol, Cinnamomum zeylanicum (Ceylon cinnamon) extract, and inulin. The combination is designed to target metabolic syndrome and its associated risk factors such as insulin resistance, dyslipidemia, hypertension, and abdominal obesity. - **Glucomannan** is a soluble fiber that can delay gastric emptying and reduce the absorption of cholesterol and glucose. - **D-chiro-inositol** acts as an insulin sensitizer by modulating insulin signaling pathways (notably PKCε-PI3K/AKT), reducing hepatic gluconeogenesis and improving glycemic control[7]. - **Cinnamomum zeylanicum** contains bioactive compounds like trans-cinnamaldehyde with anti-diabetic effects; it may inhibit protein tyrosine phosphatase 1B (PTP1B), enhancing insulin sensitivity[8]. - **Inulin** is a prebiotic fiber that improves gut microbiota composition, enhances satiety, reduces serum lipids, improves glycemic control, and supports weight management[6][5]. Clinical studies have shown this supplement can significantly reduce body weight/BMI, serum insulin levels/HOMA index (insulin resistance marker), total cholesterol/triglycerides/LDL cholesterol levels in patients with metabolic syndrome or type 2 diabetes when used alongside standard therapy such as metformin[1][2][3][6].

Brand names
Gludia
02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on glucomannan + d-chiro-inositol + cinnamomum zeylanicum + inulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucomannan + d-chiro-inositol + cinnamomum zeylanicum + inulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call